Sk Biopharmaceuticals Co Ltd Financial Flexibility Index
Sk Biopharmaceuticals Co Ltd financial flexibility index. Sk Biopharmaceuticals Co Ltd (326030) has a Financial Flexibility Index of 0.05x as of March 2026. Free cash flow of ₩20.86 Billion (operating CF ₩17.92 Billion minus capex ₩2.94 Billion) represents 0% of total liabilities (₩388.37 Billion). See Sk Biopharmaceuticals Co Ltd (326030) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sk Biopharmaceuticals Co Ltd (2016–2025)
Financial flexibility index of Sk Biopharmaceuticals Co Ltd from 2016 to 2025. Historical Financial Flexibility Index trend for Sk Biopharmaceuticals Co Ltd across 10 annual periods. Check cash flow quality index of Sk Biopharmaceuticals Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Sk Biopharmaceuticals Co Ltd Financial Flexibility Index by Year (2016–2025)
Sk Biopharmaceuticals Co Ltd financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Sk Biopharmaceuticals Co Ltd. For the full cash flow conversion analysis, see how efficiently does Sk Biopharmaceuticals Co Ltd generate cash.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | ₩205.84 Billion | ₩176.33 Billion | ₩372.04 Billion | ▲ +136.4% |
| 2024 | 0.23x | ₩108.32 Billion | ₩94.90 Billion | ₩462.83 Billion | ▲ +203.5% |
| 2023 | -0.23x | ₩-90.95 Billion | ₩-94.20 Billion | ₩402.22 Billion | ▲ +49.3% |
| 2022 | -0.45x | ₩-155.01 Billion | ₩-159.92 Billion | ₩347.68 Billion | ▼ -0.4% |
| 2021 | -0.44x | ₩-88.56 Billion | ₩-92.87 Billion | ₩199.46 Billion | ▲ +73.1% |
| 2020 | -1.65x | ₩-199.70 Billion | ₩-210.73 Billion | ₩121.17 Billion | ▼ -272.5% |
| 2019 | -0.44x | ₩-67.29 Billion | ₩-81.33 Billion | ₩152.10 Billion | ▲ +88.3% |
| 2018 | -3.79x | ₩-139.85 Billion | ₩-141.28 Billion | ₩36.91 Billion | ▼ -100.3% |
| 2017 | -1.89x | ₩-96.70 Billion | ₩-98.34 Billion | ₩51.12 Billion | ▼ -117.7% |
| 2016 | -0.87x | ₩-40.14 Billion | ₩-48.94 Billion | ₩46.21 Billion | — |